AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2008
May 23, 2008
33510_dirs_2008-05-23_3d4f5bac-0487-4604-98f6-95f925b9fbb5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2008-05-13
Reporting Person: Babcock Dwight William (Director, Interim CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-05-19 | Common Stock | P | 5000 | $0.89 | Acquired | 63307 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-05-13 | Stock Option (right to buy) | $0.75 | A | 100000 | Acquired | 2018-05-12 | Common Stock (100000) | Direct |
More from Perspective Therapeutics, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16